I agree with your comment but add that this is only an interim measure until such time a suitable candidate is appointed..no need to rush. However I have to note that with the departure of Peter Jooste we now have only 1 Director who has made an on market purchase of shares and that I think is definitely light on.
I do not now understand the hesitation when I read a line from the poster presentation dated 6th November......Initial results appear to confirm earlier studies.......this is in relation to the Phase 3 trials at a time when the initial results would certainly be known to the Board.
Come on guys time for some skin in the game to boost any doubting Thomas's.
kippax
EMS Price at posting:
2.9¢ Sentiment: Buy Disclosure: Held
